Andere talen Carisma Therapeutics, Inc.

Aandelen

CARM

US14216R1014

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,54 ^USD	+20,31%		+50,98%	-47,44%

28/06	Wall Street zal vrijdag hoger openen nu belangrijke inflatiecijfers aangeven dat de inflatie afkoelt	MT
28/06	Sectorupdate: Gezondheidszorgaandelen vrijdag voor de beurs hoger	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Wall Street Set to Open Higher Friday as Key Inflation Data Indicates Cooling Inflation	28/06
Sector Update: Health Care Stocks Higher Pre-Bell Friday	28/06
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Ahead of Key Inflation Report	28/06
Sector Update: Health Care	28/06
Carisma Therapeutics Debuts Moderna Collaboration With Solid Tumors Investigative Study; Shares Soar Premarket	28/06
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna	27/06
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna	27/06
Carisma Therapeutics' Potential Solid Tumor Therapy Gets FDA Fast Track Designation	25/06
Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum	25/06
Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors	25/06
Carisma Therapeutics, Inc. Grants FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors	25/06
Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders	13/06
Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference	30/05
Carisma Therapeutics : Corporate Presentation May 2024	16/05
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, A Novel HER2-Targeting CAR-Monocyte	16/05
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights	10/05
Carisma Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Carisma Therapeutics : Corporate Presentation May 2024	09/05
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference	06/05
Carisma Therapeutics : Corporate Presentation May 2024	02/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Carisma Therapeutics, Inc.

Aandelen

CARM

US14216R1014

Andere talen

Filters